Next Article in Journal
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids
Previous Article in Journal
Pharmacogenetics of CYP2A6, CYP2B6, and UGT2B7 in the Context of HIV Treatments in African Populations
 
 
Article

Article Versions Notes

Action Date Notes Link
article pdf uploaded. 5 December 2022 17:30 CET Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/2075-4426/12/12/2014/pdf-vor
article pdf uploaded. 6 December 2022 02:35 CET Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/2075-4426/12/12/2014/pdf-vor
article xml file uploaded 9 December 2022 04:51 CET Original file -
article xml uploaded. 9 December 2022 04:51 CET Update https://0-www-mdpi-com.brum.beds.ac.uk/2075-4426/12/12/2014/xml
article pdf uploaded. 9 December 2022 04:51 CET Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/2075-4426/12/12/2014/pdf
article html file updated 9 December 2022 04:52 CET Original file -
article html file updated 4 March 2023 01:30 CET Update https://0-www-mdpi-com.brum.beds.ac.uk/2075-4426/12/12/2014/html
Back to TopTop